Press Releases
Nov 22, 2023
Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference
Nov 09, 2023
Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 03, 2023
Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023
Sep 28, 2023
Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day
Sep 25, 2023
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
Sep 06, 2023
Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Sep 05, 2023
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual “R&D Day”
Aug 03, 2023
Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 27, 2023
Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023
Jun 26, 2023
Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes